Dr. Lockshin discusses the clinical utility of Roflumilast as a topical treatment option for patients with psoriasis, highlighting its effectiveness across mild, moderate, and even more severe presentations. Available in both cream and foam formulations, roflumilast offers flexibility in treating different body areas and patient needs.
Topics Covered
- Mechanism of action of roflumilast as a PDE-4 inhibitor
- Benefits of topical formulations (cream vs foam)
- Efficacy across varying severities of psoriasis
- Practical considerations for incorporating roflumilast into treatment plans
Explore Related Resources